PharmaShots | Incisive News in 3 Shots

Subscribe Now

Duchenne Muscular Dystrophy DMD

Sarepta's Amondys 45 (casimersen) Receives the US FDA's Approval for DMD in Patients Amenable to Skipping Exon 4

Sarepta's Amondys 45 (casimersen) Receives the US FDA's Approval for DMD in Patients Amenable to Skipping Exon 4

February 25, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us